Luk Van Parijs

9.4k total citations · 5 hit papers
35 papers, 6.9k citations indexed

About

Luk Van Parijs is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Luk Van Parijs has authored 35 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 16 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Luk Van Parijs's work include Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (9 papers). Luk Van Parijs is often cited by papers focused on Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (9 papers). Luk Van Parijs collaborates with scholars based in United States, Germany and China. Luk Van Parijs's co-authors include Abul K. Abbas, Yosef Refaeli, Christopher P. Dillon, Michael T. McManus, Lili Yang, Douglas A. Rubinson, Rudolf Jaenisch, Víctor Pérez, Jürg Tschopp and Alexander Ibraghimov and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Genetics.

In The Last Decade

Luk Van Parijs

33 papers receiving 6.8k citations

Hit Papers

A lentivirus-based system to functionally silence genes i... 1997 2026 2006 2016 2003 1998 1997 1998 2004 400 800 1.2k

Peers

Luk Van Parijs
Bruno Luckow Germany
Luk Van Parijs
Citations per year, relative to Luk Van Parijs Luk Van Parijs (= 1×) peers Bruno Luckow

Countries citing papers authored by Luk Van Parijs

Since Specialization
Citations

This map shows the geographic impact of Luk Van Parijs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luk Van Parijs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luk Van Parijs more than expected).

Fields of papers citing papers by Luk Van Parijs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luk Van Parijs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luk Van Parijs. The network helps show where Luk Van Parijs may publish in the future.

Co-authorship network of co-authors of Luk Van Parijs

This figure shows the co-authorship network connecting the top 25 collaborators of Luk Van Parijs. A scholar is included among the top collaborators of Luk Van Parijs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luk Van Parijs. Luk Van Parijs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Refaeli, Yosef, Luk Van Parijs, Stephen I. Alexander, & Abul K. Abbas. (2012). Interferon γ is required for activation-induced death of T lymphocytes. The Journal of Experimental Medicine. 209(5). 1049–1049.
2.
Parijs, Luk Van, Daniel A. Peterson, & Abul K. Abbas. (2009). The Fas/Fas Ligand Pathway and Bcl-2 Regulate T Cell Responses to Model Self and Foreign Antigens. Immunity. 30(4). 611–611. 1 indexed citations
3.
Parijs, Luk Van, Yosef Refaeli, James D. Lord, et al.. (2009). Uncoupling IL-2 Signals that Regulate T Cell Proliferation, Survival, and Fas-Mediated Activation-Induced Cell Death. Immunity. 30(4). 611–611. 4 indexed citations
4.
Parijs, Luk Van, Víctor Pérez, & Abul K. Abbas. (2007). Mechanisms of Peripheral T Cell Tolerance. Novartis Foundation symposium. 215. 5–20. 19 indexed citations
5.
Zhang, Qiang, Thomas L. Jang, Ximing J. Yang, et al.. (2005). Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells. The Prostate. 66(3). 235–247. 19 indexed citations
6.
Ventura, Andrea, Alexander Meissner, Christopher P. Dillon, et al.. (2004). Cre-lox-regulated conditional RNA interference from transgenes. Proceedings of the National Academy of Sciences. 101(28). 10380–10385. 500 indexed citations breakdown →
7.
Song, Jianxun, et al.. (2004). The costimulation-regulated duration of PKB activation controls T cell longevity. Nature Immunology. 5(2). 150–158. 169 indexed citations
8.
Hou, Wu-Shiun & Luk Van Parijs. (2004). A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nature Immunology. 5(6). 583–589. 148 indexed citations
9.
Antov, Andrey, Lili Yang, Monika Vig, David Baltimore, & Luk Van Parijs. (2003). Essential Role for STAT5 Signaling in CD25+CD4+ Regulatory T Cell Homeostasis and the Maintenance of Self-Tolerance. The Journal of Immunology. 171(7). 3435–3441. 168 indexed citations
10.
Nencioni, Alessio, Kirsten Lauber, Frank Grünebach, et al.. (2003). Cyclopentenone Prostaglandins Induce Lymphocyte Apoptosis by Activating the Mitochondrial Apoptosis Pathway Independent of External Death Receptor Signaling. The Journal of Immunology. 171(10). 5148–5156. 46 indexed citations
11.
Kelly, Erin, A Jin Won, Yosef Refaeli, & Luk Van Parijs. (2002). IL-2 and Related Cytokines Can Promote T Cell Survival by Activating AKT. The Journal of Immunology. 168(2). 597–603. 94 indexed citations
12.
Shah, Ali, William Tabayoyong, Simon Kimm, et al.. (2002). Reconstitution of Lethally Irradiated Adult Mice with Dominant Negative TGF-β Type II Receptor-Transduced Bone Marrow Leads to Myeloid Expansion and Inflammatory Disease. The Journal of Immunology. 169(7). 3485–3491. 34 indexed citations
13.
McManus, Michael T., Brian B. Haines, Christopher P. Dillon, et al.. (2002). Small Interfering RNA-Mediated Gene Silencing in T Lymphocytes. The Journal of Immunology. 169(10). 5754–5760. 184 indexed citations
14.
Refaeli, Yosef, Luk Van Parijs, Stephen I. Alexander, & Abul K. Abbas. (2002). Interferon γ Is Required for Activation-induced Death of T Lymphocytes. The Journal of Experimental Medicine. 196(7). 999–1005. 371 indexed citations
15.
Lois, Carlos, Yosef Refaeli, F. Xiao‐Feng Qin, & Luk Van Parijs. (2001). Retroviruses as tools to study the immune system. Current Opinion in Immunology. 13(4). 496–504. 27 indexed citations
16.
Cherry, Sara, Detlev Biniszkiewicz, Luk Van Parijs, David Baltimore, & Rudolf Jaenisch. (2000). Retroviral Expression in Embryonic Stem Cells and Hematopoietic Stem Cells. Molecular and Cellular Biology. 20(20). 7419–7426. 220 indexed citations
17.
Refaeli, Yosef, et al.. (1999). Genetic models of abnormal apoptosis in lymphocytes. Immunological Reviews. 169(1). 273–282. 31 indexed citations
18.
Refaeli, Yosef, Luk Van Parijs, Cheryl A. London, Jürg Tschopp, & Abul K. Abbas. (1998). Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis. Immunity. 8(5). 615–623. 521 indexed citations breakdown →
19.
Parijs, Luk Van, et al.. (1997). Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. The Journal of Immunology. 158(8). 3738–3745. 159 indexed citations
20.
Parijs, Luk Van, Alexander Ibraghimov, & Abul K. Abbas. (1996). The Roles of Costimulation and Fas in T Cell Apoptosis and Peripheral Tolerance. Immunity. 4(3). 321–328. 311 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026